Skip to main content
Top
Published in: Endocrine 2/2017

01-11-2017 | Endocrine Imaging

Into the void: a giant aneurysm mimicking a macroprolactinoma

Authors: Elisa Baranski Lamback, Hugo Rodrigues Gouveia, Daniel Alves Bulzico

Published in: Endocrine | Issue 2/2017

Login to get access

Excerpt

A previously well menopaused 51-year-old female presented with a 6-months history of headache, galactorrhea and peripheral vision loss. During investigation, mild hyperprolactinemia was found and a 1.7 cm × 1.4 cm × 1.3 cm intrasellar lesion, with heterogenous signal in T1W and hypointense in T2W, with suprasselar extension abutting the optic chiasm was detected on magnetic resonance imaging (MRI) (Fig. 1a, b). After an initial diagnosis of a macroprolactinoma, the patient was started on cabergoline therapy. Four months later, low levels of basal cortisol and FSH lead to the diagnosis of panhypopituitarism. Due to the emergence of fatigue, weight loss and nausea, a new MRI was performed revealing a suprasellar lesion, of approximately 2.5 cm × 1.9 cm × 1.6 cm, with a flow void phenomenon in T1W and T2W sequences (Fig. 1c, d). Therefore, because of the mass location and the flow void phenomenon, a giant circle of Willis aneurysm was suspected. A computed tomography (CT) angiogram revealed a saccular aneurysm of the internal carotid artery (IC), with sellar extension (Fig. 1e, f). Then an arteriography showed mirror aneurysms of the carotid siphon: a giant saccular aneurysm of 3 cm on the right and 0.4 cm on the left-side (Fig. 1g, h). Glucocorticoid coverage led to clinical improvement. An endovascular flow diverter was opted as the best treatment option.
Literature
1.
go back to reference H.M. Heshmati, V. Fatourechi, S.A. Dagam, D.G. Piepgras, Hypopituitarism caused by intrasellar aneurysms. Mayo Clin. Proc. 76(8), 789–793 (2001)CrossRefPubMed H.M. Heshmati, V. Fatourechi, S.A. Dagam, D.G. Piepgras, Hypopituitarism caused by intrasellar aneurysms. Mayo Clin. Proc. 76(8), 789–793 (2001)CrossRefPubMed
2.
go back to reference B.W. Hanak, G. Zada, V.V. Nayar, R. Thiex, R. Du, A.L. Day et al. Cerebral aneurysms with intrasellar extension: a systematic review of clinical, anatomical, and treatment characteristics. J. Neurosurg. 116(1), 164–178 (2012)CrossRefPubMed B.W. Hanak, G. Zada, V.V. Nayar, R. Thiex, R. Du, A.L. Day et al. Cerebral aneurysms with intrasellar extension: a systematic review of clinical, anatomical, and treatment characteristics. J. Neurosurg. 116(1), 164–178 (2012)CrossRefPubMed
4.
go back to reference R. Wang, D. Zhang, J. Zhao, S. Wang, Y. Zhao, H. Niu, A comparative study of 43 patients with mirror-like intracranial aneurysms: risk factors, treatment, and prognosis. Neuropsychiatr. Dis. Treat. 19(10), 2231–2237 (2014) R. Wang, D. Zhang, J. Zhao, S. Wang, Y. Zhao, H. Niu, A comparative study of 43 patients with mirror-like intracranial aneurysms: risk factors, treatment, and prognosis. Neuropsychiatr. Dis. Treat. 19(10), 2231–2237 (2014)
5.
go back to reference J. Gondim, M. Schops, E. Ferreira, Hypopituitarism and amenorrhea-galactorrhea syndrome caused by thrombosis of both internal carotid artery and giant intrasellar aneurysm: case report. Arq. Neuropsiquiatr. 62(1), 158–161 (2004)CrossRefPubMed J. Gondim, M. Schops, E. Ferreira, Hypopituitarism and amenorrhea-galactorrhea syndrome caused by thrombosis of both internal carotid artery and giant intrasellar aneurysm: case report. Arq. Neuropsiquiatr. 62(1), 158–161 (2004)CrossRefPubMed
Metadata
Title
Into the void: a giant aneurysm mimicking a macroprolactinoma
Authors
Elisa Baranski Lamback
Hugo Rodrigues Gouveia
Daniel Alves Bulzico
Publication date
01-11-2017
Publisher
Springer US
Published in
Endocrine / Issue 2/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1419-x

Other articles of this Issue 2/2017

Endocrine 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.